Nuo Therapeutics (AURX) Operating Margin (2010 - 2026)
Nuo Therapeutics (AURX) recorded Operating Margin of -9.42% in Q2 2026, up 83.70 percentage points from -93.12% a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) Operating Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Nuo Therapeutics' Operating Margin came in at -42.15% as of Jun 30, 2026, up 91.35 percentage points year-over-year; for FY2025, it was -75.95%, up 104.09 percentage points from FY2024.
- Annual Operating Margin has increased for three straight years, with a three-year change of +2882.26 percentage points (FY2022 to FY2025).
- Across earlier years, Operating Margin came in at -180.04% in FY2024 (+340.61 pp), -520.65% in FY2023 (+2437.56 pp) and -2958.21% in FY2022.
- The Q2 2026 figure is the highest quarterly Operating Margin since Q4 2019.
- The year-over-year gain in Operating Margin has ranged between 55.46 percentage points (Q2 2025) and 2043.99 percentage points (Q3 2023) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 253.62 Bn | 232.65 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 175.99 Bn | 146.42 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 164.43 Bn | 148.23 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 154.62 Bn | 134.04 Bn | 1.96 Bn | 33.60% |
| 5 | Medtronic | 120.99 Bn | 86.24 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 116.60 Bn | 102.72 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 66.31 Bn | 61.08 Bn | 3.85 Bn | 21.65% |
| 8 | Becton Dickinson | 54.00 Bn | 51.14 Bn | 2.32 Bn | 13.31% |
| 9 | Edwards Lifesciences | 51.33 Bn | 35.34 Bn | 1.35 Bn | 29.48% |
| 10 | Nuo Therapeutics | 61.03 Mn | 59.20 Mn | 1.17 Mn | -9.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.42% |
| Dec 31, 2025 | -52.82% |
| Sep 30, 2025 | -52.33% |
| Jun 30, 2025 | -93.12% |
| Mar 31, 2025 | -153.83% |
| Dec 31, 2024 | -159.35% |
| Sep 30, 2024 | -155.65% |
| Jun 30, 2024 | -148.58% |
| Mar 31, 2024 | -302.35% |
| Dec 31, 2023 | -330.99% |
| Sep 30, 2023 | -339.97% |
| Jun 30, 2023 | -737.44% |
| Mar 31, 2023 | -1,399.66% |
| Dec 31, 2022 | -1,301.60% |
| Sep 30, 2022 | -2,383.96% |
| Dec 31, 2019 | 1,505.55% |
| Sep 30, 2019 | -66.85% |
| Jun 30, 2019 | -888.59% |
| Mar 31, 2019 | -1,559.64% |
| Dec 31, 2018 | 19.39% |
API Access
Nuo Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();